Search results for "Urinary tract infections"

Results 11 - 20 of about 69 for "Urinary tract infections".

Sort by: Relevance | Newest | Oldest

New cardiovascular indication approved for diabetes drug

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/04/new-cardiovascular-indication-approved-for-diabetes-drug.htm
1 Apr 2022

Urinary antiseptic noninferior to antibiotics for recurrent UTI prevention in women

Methenamine hippurate was noninferior to daily, low-dose antibiotics, the current standard prophylactic treatment, in preventing symptomatic, antibiotic-treated urinary tract infection (UTI) episodes in women with recurrent UTIs, a yearlong U.K. trial found.
https://immattersacp.org/weekly/archives/2022/03/15/1.htm
15 Mar 2022

MKSAP Quiz: Recurrent symptomatic lower UTIs

A 32-year-old woman undergoes consultation for recurrent symptomatic lower urinary tract infections. They have increased in frequency over the past 3 years to a rate of about two times per year. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2021/12/21/3.htm
21 Dec 2021

Flu-like illnesses appeared to spread through primary care office visits

A new study's findings on the spread of influenza offered lessons on reopenings of outpatient clinics during the pandemic and the value of virtual visits for patients with suspected respiratory infections, the authors said.
https://immattersacp.org/weekly/archives/2021/08/10/2.htm
10 Aug 2021

A week of antibiotics resolved simple UTI in men at similar rates as longer therapy

A randomized trial comparing seven- and 14-day courses of ciprofloxacin or trimethoprim/sulfamethoxazole for afebrile, outpatient men with urinary tract infections (UTIs) found similar rates of symptom resolution with either strategy.
https://immattersacp.org/weekly/archives/2021/08/03/1.htm
3 Aug 2021

New warning on NSAIDs; drug approved for flu exposures

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/01/new-warning-on-nsaids-drug-approved-for-flu-exposures.htm
1 Jan 2021

IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections

New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
https://immattersacp.org/weekly/archives/2020/09/15/4.htm
15 Sep 2020